Ying Zhu

Genentech Inc
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (21)

Year:

2026

Single-cell proteomic (scProteomic) measurements of peripheral blood mononuclear cells (PBMCs) are of considerable value in human health, given their involvement in the maintenance of healthy and diseased states. However, the high heterogeneity and relatively small size of immune cell types demand maximal throughput and sensitivity in proteomic measurements that have yet to be fully realized. Here, we describe an approach that addresses sensitivity and throughput through the implementation of Real-Time spectral Library Searching (RTLS), TMTpro 32-plex labelling, an updated nested-nanodroplet processing in One pot for Trace Samples (N2), and a dual-column liquid chromatography system. By prioritizing tandem mass spectrometry (MS2) features with high similarity to library spectra, RTLS enables greater identification depth and feature reproducibility than a standard shotgun MS2 approach in low-input and single-cell samples. The platform permitted 660 single PBMCs to be measured per day, with an average of 750 protein identifications per cell and 1,648 proteins in total, achieving the necessary throughput and depth to characterize immune cell populations. Application of this scProteomic method and a new cell typing informatics approach to 2,130 PBMCs enabled the identification of both major and low-frequency cell types (∼1-2%), as well as associated proteomic markers.

Year:

2026

Clinical information of patients in scRNA-seq discovery cohort, flow cytometry validation cohort and proteomics validation cohort, including age, gender, race, ISS stage, time to disease progression (TTPD). Disease stage for WashU cohort 1.

Year:

2025

Novelty description of candidate tumor markers. Each gene is ranked according to existing literature and/or clinical trials investigating its role in multiple myeloma. Representative studies are listed.

Year:

2025

NetMHC analysis output for tissue-specific intracellular genes. Only peptides identified as strong binders (% rank

Year:

2025

Multiple myeloma (MM) is a highly refractory hematologic cancer. Targeted immunotherapy has shown promise in MM but remains hindered by the challenge of identifying specific yet broadly representative tumor markers. We analyzed 53 bone marrow (BM) aspirates from 41 MM patients using an unbiased, high-throughput pipeline for therapeutic target discovery via single-cell transcriptomic profiling, yielding 38 MM marker genes encoding cell-surface proteins and 15 encoding intracellular proteins. Of these, 20 candidate genes were highlighted that are not yet under clinical study, 11 of which were previously uncharacterized as therapeutic targets. The findings were cross-validated using bulk RNA sequencing, flow cytometry, and proteomic mass spectrometry of MM cell lines and patient BM, demonstrating high overall concordance across data types. Independent discovery using bulk RNA sequencing reiterated top candidates, further affirming the ability of single-cell transcriptomics to accurately capture marker expression despite limitations in sample size or sequencing depth. Target dynamics and heterogeneity were further examined using both transcriptomic and immuno-imaging methods. In summary, this study presents a robust and broadly applicable strategy for identifying tumor markers to better inform the development of targeted cancer therapy. Significance: Single-cell transcriptomic profiling and multiomic cross-validation to uncover therapeutic targets identifies 38 myeloma marker genes, including 11 transcribing surface proteins with previously uncharacterized potential for targeted antitumor therapy.

Year:

2025

Clinical information of patients in scRNA-seq discovery cohort, flow cytometry validation cohort and proteomics validation cohort, including age, gender, race, ISS stage, time to disease progression (TTPD). Disease stage for WashU cohort 1.

Year:

2024

Multiple myeloma (MM) is a highly refractory hematological cancer. Targeted immunotherapy has shown promise in MM but remains hindered by the challenge of identifying specific yet broadly representative tumor markers. We analyzed 53 bone marrow (BM) aspirates from 41 MM patients using an unbiased, high-throughput pipeline for therapeutic target discovery via single cell transcriptomic profiling, yielding 38 MM marker genes encoding cell-surface proteins and 15 encoding intracellular proteins. Of these, 20 candidate genes were highlighted that are not yet under clinical study, 11 of which are previously uncharacterized as therapeutic targets. The findings were cross-validated using bulk RNA-sequencing, flow cytometry, and proteomic mass spectrometry of MM cell lines and patient BM, demonstrating high overall concordance across data types. Independent discovery using bulk RNA-sequencing reiterated top candidates, further affirming the ability of single cell transcriptomics to accurately capture marker expression despite limitations in sample size or sequencing depth. Target dynamics and heterogeneity were further examined using both transcriptomic and immuno-imaging methods. In summary, this study presents a robust and broadly applicable strategy for identifying tumor markers to better inform the development of targeted cancer therapy.

Year:

2024

Novelty description of candidate tumor markers. Each gene is ranked according to existing literature and/or clinical trials investigating its role in multiple myeloma. Representative studies are listed.

Year:

2024

Novelty description of candidate tumor markers. Each gene is ranked according to existing literature and/or clinical trials investigating its role in multiple myeloma. Representative studies are listed.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (27)

Xueyun Zheng

Scientist

Pacific Northwest National Laboratory

UNITED STATES
View details

Feng Chen

Professor

Washington University in St. Louis

UNITED STATES
View details

Fengchao Yu

University of Michigan

UNITED STATES
View details

James Fulcher

Staff Scientist

Pacific Northwest National Laboratory

UNITED STATES
View details

David Degnan

Assistant Teaching Professor

University of Oregon

UNITED STATES
View details

Vladislav Petyuk

scientist

Pacific Northwest National Laboratory

UNITED STATES
View details

Song Cao

Assistant Professor

Washington University in St. Louis

UNITED STATES
View details

Geremy Clair

Scientist

Pacific Northwest National Laboratory

UNITED STATES
View details

Mowei Zhou

Qiushi Scholar for Experiments

Zhejiang University

CHINA
View details

Ryan Kelly

Associate Professor

Brigham Young University

UNITED STATES
View details

Mark Fiala

Assistant Professor

Washington University School of Medicine

UNITED STATES
View details

Wei-Jun Qian

Staff Scientist

Pacific Northwest National Laboratory

UNITED STATES
View details

John F. DiPersio

Director, Center for Gene and Cellular Immunotherapy

Washington University in St. Louis

UNITED STATES
View details

Scott Goldsmith

Assistant Professor

City Of Hope National Medical Center

UNITED STATES
View details

Micah Donor

Assistant Professor

George Fox University

UNITED STATES
View details

Dylan Ross

Data Scientist

Pacific Northwest National Laboratory

UNITED STATES
View details

Martha Campbell-Thompson

Professor

University of Florida

UNITED STATES
View details

Tao Liu

Sr. Staff Scientist

Pacific Northwest National Laboratory

UNITED STATES
View details

Ravi Vij

Washington University School of Medicine

UNITED STATES
View details

Chia-Feng Tsai

Scorpion Therapeutics (United States)

UNITED STATES
View details

Clayton Mathews

Professor

University of Florida

UNITED STATES
View details

Leah Gehrs

The University of Alabama

UNITED STATES
View details

Li Ding

Associate Professor

Washington University in Saint Louis School of Medicine

UNITED STATES
View details

Ernesto Nakayasu

Scientist

Pacific Northwest National Laboratory

UNITED STATES
View details

Yehia Ibrahim

Scientist

Pacific Northwest National Laboratory

UNITED STATES
View details

Michael Rettig

Washington University in St. Louis

UNITED STATES
View details

Alexey Nesvizhskii

Professor

University of Michigan

UNITED STATES
View details